Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of South Carolina

About this trial

This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.

Eligibility criteria

Qualifiers

African American

Male and female

Living in a Medically Underserved Area and/or a designated rural area of South Carolina

≥ 18 years and above

Disqualifiers

Survivor and Carepartner exclusion criteria • Enrolled in related clinical trials

Trial design

Treatments tested in this trial

  • Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM)

Treatment groups

500 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of South Carolina

Lead sponsor

National Institute of Nursing Research (NINR)

Collaborator